Announcements & Media Coverage

Total Voting Rights - 7:05 28/28/2020
Hemogenyx Pharmaceuticals plc (“Hemogenyx” or the “Company”)   Total Voting Rights   Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total issued share capital of the Company consists of 397,253,969 ordinary shares of 1 pence each, none of which are held in treasury. Therefore,...